Metronomic Capecitabine Plus Aromatase Inhibitor as Initial Therapy in Patients With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: The Phase III MECCA Trial
节拍式卡培他滨联合芳香化酶抑制剂作为激素受体阳性、人表皮生长因子受体2阴性转移性乳腺癌患者的初始治疗：III期MECCA试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.24.00938
Hong, Ruo-Xi; Xu, Fei; Xia, Wen; Teng, Yue-E; Ouyang, Qu-Chang; Zheng, Qiu-Fan; Yuan, Zhong-Yu; Chen, Dong-Shao; Jiang, Kui-Kui; Lin, Ying; Dai, Zhen; Liu, Xin-Lan; Chen, Qian-Jun; Wu, Xin-Hong; Shi, Yan-Xia; Huang, Jia-Jia; An, Xin; Xue, Cong; Bi, Xi-Wen; Chen, Mei-Ting; Li, Hui; Yao, He-Rui; Zou, Guo-Rong; Huang, Heng; Zhang, Jing-Min; Wang, Shu-Sen
